Taejong Song
Papers
2
Total Citations
18
H-Index
2
About
Dr. Taejong Song is a leading gynecologic surgeon whose research focuses on advancing minimally invasive techniques for complex pelvic surgeries, particularly in oncology and fibroid management. His work directly addresses critical challenges in the field, such as reducing operative blood loss and preventing tumor spillage during cancer surgery. A major contribution is his leadership of the SOLUTION trial (2022), a multi-centre phase II study that rigorously evaluates the safety and efficacy of using endoscopic staplers during laparoscopic or robotic radical hysterectomy to inhibit tumor dissemination in cervical cancer—a response to the concerning findings of the landmark LACC trial. This work has already garnered 15 citations, underscoring its relevance to a pressing clinical debate. Additionally, Dr. Song has pioneered the vascular control technique for robot-assisted myomectomy, demonstrating in a 2019 study how temporary occlusion of uterine vessels can significantly reduce blood loss compared to conventional methods. Through these innovative, evidence-based approaches, Dr. Song is shaping safer, more effective surgical standards for women’s health.
Research Focus
Key Achievements
Top Papers
- 1
- 2